Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

A comprehensive study of calcific aortic stenosis: from rabbit to human samples.

Mourino-Alvarez L, Baldan-Martin M, Sastre-Oliva T, Martin-Lorenzo M, Maroto AS, Corbacho-Alonso N, Rincon R, Martin-Rojas T, Lopez-Almodovar LF, Alvarez-Llamas G, Vivanco F, Padial LR, de la Cuesta F, Barderas MG.

Dis Model Mech. 2018 Jun 19;11(6). pii: dmm033423. doi: 10.1242/dmm.033423.

2.

Author Correction: Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.

Martin-Lorenzo M, Gonzalez-Calero L, Martinez PJ, Baldan-Martin M, Lopez JA, Ruiz-Hurtado G, de la Cuesta F, Segura J, Vazquez J, Vivanco F, Barderas MG, Ruilope LM, Alvarez-Llamas G.

Sci Rep. 2018 Mar 2;8(1):4154. doi: 10.1038/s41598-018-22185-0.

3.

Urine metabolomics insight into acute kidney injury point to oxidative stress disruptions in energy generation and H2S availability.

Martin-Lorenzo M, Gonzalez-Calero L, Ramos-Barron A, Sanchez-Niño MD, Gomez-Alamillo C, García-Segura JM, Ortiz A, Arias M, Vivanco F, Alvarez-Llamas G.

J Mol Med (Berl). 2017 Dec;95(12):1399-1409. doi: 10.1007/s00109-017-1594-5. Epub 2017 Oct 4.

PMID:
28975359
4.

Citric Acid Metabolism in Resistant Hypertension: Underlying Mechanisms and Metabolic Prediction of Treatment Response.

Martin-Lorenzo M, Martinez PJ, Baldan-Martin M, Ruiz-Hurtado G, Prado JC, Segura J, de la Cuesta F, Barderas MG, Vivanco F, Ruilope LM, Alvarez-Llamas G.

Hypertension. 2017 Nov;70(5):1049-1056. doi: 10.1161/HYPERTENSIONAHA.117.09819. Epub 2017 Sep 5.

PMID:
28874460
5.

Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria.

Martin-Lorenzo M, Gonzalez-Calero L, Martinez PJ, Baldan-Martin M, Lopez JA, Ruiz-Hurtado G, de la Cuesta F, Segura J, Vazquez J, Vivanco F, Barderas MG, Ruilope LM, Alvarez-Llamas G.

Sci Rep. 2017 Aug 21;7(1):8894. doi: 10.1038/s41598-017-09042-2. Erratum in: Sci Rep. 2018 Mar 2;8(1):4154.

6.

Urinary exosomes reveal protein signatures in hypertensive patients with albuminuria.

Gonzalez-Calero L, Martínez PJ, Martin-Lorenzo M, Baldan-Martin M, Ruiz-Hurtado G, de la Cuesta F, Calvo E, Segura J, Lopez JA, Vázquez J, Barderas MG, Ruilope LM, Vivanco F, Alvarez-Llamas G.

Oncotarget. 2017 Jul 4;8(27):44217-44231. doi: 10.18632/oncotarget.17787.

7.

Hypertensive patients exhibit an altered metabolism. A specific metabolite signature in urine is able to predict albuminuria progression.

Gonzalez-Calero L, Martin-Lorenzo M, Martínez PJ, Baldan-Martin M, Ruiz-Hurtado G, Segura J, de la Cuesta F, Barderas MG, Ruilope LM, Vivanco F, Alvarez-Llamas G.

Transl Res. 2016 Dec;178:25-37.e7. doi: 10.1016/j.trsl.2016.07.003. Epub 2016 Jul 15.

PMID:
27477079
8.

Urinary Kininogen-1 and Retinol binding protein-4 respond to Acute Kidney Injury: predictors of patient prognosis?

Gonzalez-Calero L, Martin-Lorenzo M, Ramos-Barron A, Ruiz-Criado J, Maroto AS, Ortiz A, Gomez-Alamillo C, Arias M, Vivanco F, Alvarez-Llamas G.

Sci Rep. 2016 Jan 21;6:19667. doi: 10.1038/srep19667.

9.

Urinary alpha-1 antitrypsin and CD59 glycoprotein predict albuminuria development in hypertensive patients under chronic renin-angiotensin system suppression.

Gonzalez-Calero L, Martin-Lorenzo M, de la Cuesta F, Maroto AS, Baldan-Martin M, Ruiz-Hurtado G, Pulido-Olmo H, Segura J, Barderas MG, Ruilope LM, Vivanco F, Alvarez-Llamas G.

Cardiovasc Diabetol. 2016 Jan 16;15:8. doi: 10.1186/s12933-016-0331-7.

10.

Cytoskeleton deregulation and impairment in amino acids and energy metabolism in early atherosclerosis at aortic tissue with reflection in plasma.

Martin-Lorenzo M, Gonzalez-Calero L, Maroto AS, Martinez PJ, Zubiri I, de la Cuesta F, Mourino-Alvarez L, Barderas MG, Heredero A, Aldamiz-Echevarría G, Vivanco F, Alvarez-Llamas G.

Biochim Biophys Acta. 2016 Apr;1862(4):725-732. doi: 10.1016/j.bbadis.2015.12.006. Epub 2015 Dec 7.

11.

Molecular histology of arteries: mass spectrometry imaging as a novel ex vivo tool to investigate atherosclerosis.

Martin-Lorenzo M, Alvarez-Llamas G, McDonnell LA, Vivanco F.

Expert Rev Proteomics. 2016;13(1):69-81. doi: 10.1586/14789450.2016.1116944. Epub 2015 Dec 4. Review.

PMID:
26558814
12.

KLK1 and ZG16B proteins and arginine-proline metabolism identified as novel targets to monitor atherosclerosis, acute coronary syndrome and recovery.

Martin-Lorenzo M, Zubiri I, Maroto AS, Gonzalez-Calero L, Posada-Ayala M, de la Cuesta F, Mourino-Alvarez L, Lopez-Almodovar LF, Calvo-Bonacho E, Ruilope LM, Padial LR, Barderas MG, Vivanco F, Alvarez-Llamas G.

Metabolomics. 2015;11(5):1056-1067. Epub 2014 Dec 14.

13.

Lipid and protein maps defining arterial layers in atherosclerotic aorta.

Martin-Lorenzo M, Balluff B, Maroto AS, Carreira RJ, van Zeijl RJ, Gonzalez-Calero L, de la Cuesta F, Barderas MG, Lopez-Almodovar LF, Padial LR, McDonnell LA, Vivanco F, Alvarez-Llamas G.

Data Brief. 2015 Jun 24;4:328-31. doi: 10.1016/j.dib.2015.06.005. eCollection 2015 Sep.

14.

Molecular anatomy of ascending aorta in atherosclerosis by MS Imaging: Specific lipid and protein patterns reflect pathology.

Martin-Lorenzo M, Balluff B, Maroto AS, Carreira RJ, van Zeijl RJ, Gonzalez-Calero L, de la Cuesta F, Barderas MG, Lopez-Almodovar LF, Padial LR, McDonnell LA, Vivanco F, Alvarez-Llamas G.

J Proteomics. 2015 Aug 3;126:245-51. doi: 10.1016/j.jprot.2015.06.005. Epub 2015 Jun 12.

PMID:
26079611
15.

Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes.

Zubiri I, Posada-Ayala M, Benito-Martin A, Maroto AS, Martin-Lorenzo M, Cannata-Ortiz P, de la Cuesta F, Gonzalez-Calero L, Barderas MG, Fernandez-Fernandez B, Ortiz A, Vivanco F, Alvarez-Llamas G.

Transl Res. 2015 Nov;166(5):474-484.e4. doi: 10.1016/j.trsl.2015.05.007. Epub 2015 May 23.

PMID:
26072307
16.

Exosomes: a potential key target in cardio-renal syndrome.

Gonzalez-Calero L, Martin-Lorenzo M, Alvarez-Llamas G.

Front Immunol. 2014 Oct 8;5:465. doi: 10.3389/fimmu.2014.00465. eCollection 2014. Review.

17.

30μm spatial resolution protein MALDI MSI: In-depth comparison of five sample preparation protocols applied to human healthy and atherosclerotic arteries.

Martin-Lorenzo M, Balluff B, Sanz-Maroto A, van Zeijl RJ, Vivanco F, Alvarez-Llamas G, McDonnell LA.

J Proteomics. 2014 Aug 28;108:465-8. doi: 10.1016/j.jprot.2014.06.013. Epub 2014 Jun 25.

PMID:
24972319
18.

Urine 2DE proteome analysis in healthy condition and kidney disease.

Martin-Lorenzo M, Gonzalez-Calero L, Zubiri I, Diaz-Payno PJ, Sanz-Maroto A, Posada-Ayala M, Ortiz A, Vivanco F, Alvarez-Llamas G.

Electrophoresis. 2014 Sep;35(18):2634-41. doi: 10.1002/elps.201300601. Epub 2014 Aug 14.

PMID:
24913465
19.

Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.

Zubiri I, Posada-Ayala M, Sanz-Maroto A, Calvo E, Martin-Lorenzo M, Gonzalez-Calero L, de la Cuesta F, Lopez JA, Fernandez-Fernandez B, Ortiz A, Vivanco F, Alvarez-Llamas G.

J Proteomics. 2014 Jan 16;96:92-102. doi: 10.1016/j.jprot.2013.10.037. Epub 2013 Nov 7.

PMID:
24211404
20.

Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease.

Posada-Ayala M, Zubiri I, Martin-Lorenzo M, Sanz-Maroto A, Molero D, Gonzalez-Calero L, Fernandez-Fernandez B, de la Cuesta F, Laborde CM, Barderas MG, Ortiz A, Vivanco F, Alvarez-Llamas G.

Kidney Int. 2014 Jan;85(1):103-11. doi: 10.1038/ki.2013.328. Epub 2013 Sep 18.

21.

A role for the membrane proteome in human chronic kidney disease erythrocytes.

Alvarez-Llamas G, Zubiri I, Maroto AS, de la Cuesta F, Posada-Ayala M, Martin-Lorenzo M, Barderas MG, Fernandez-Fernandez B, Ramos A, Ortiz A, Vivanco F.

Transl Res. 2012 Nov;160(5):374-83. doi: 10.1016/j.trsl.2012.06.004. Epub 2012 Jul 17.

PMID:
22814359

Supplemental Content

Loading ...
Support Center